Showing results (41-50 of 205) with videos related to
Sort By:
Pageof 21
British Journal of Cancer|March 1, 1989
The size of clinical trials in cancer research--what are the current needs? Medical Research Council Cancer Therapy CommitteeL S FreedmanAnnals of Internal Medicine|February 1, 1984
Clinical staging for cutaneous T-cell lymphomaS I Lamberg, S B Green, D P Byar, et al.Cancer|September 1, 1976
Response of serum cholesterol and triglycerides to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancerU S Seal, R P Doe, D P Byar, et al.Cancer|September 1, 1976
Response of plasma fibrinogen and plasminogen to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancerU S Seal, R P Doe, D P Byar, et al.The Journal of Urology|April 1, 1975
Correlation of pre-treatment serum 17-hydroxycorticosteroid values with survival in patients with prostatic cancerC E Blackard, D P Byar, U S Seal, et al.Controlled Clinical Trials|February 1, 1992
Aspects of statistical design for the Community Intervention Trial for Smoking Cessation (COMMIT)M H Gail, D P Byar, T F Pechacek, et al.Controlled Clinical Trials|April 1, 1990
Issues in the design of drug trials for AIDSS B Green, S S Ellenberg, D Finkelstein, et al.American Journal of Epidemiology|September 15, 1995
Interplay between design and analysis for behavioral intervention trials with community as the unit of randomizationS B Green, D K Corle, M H Gail, et al.Cancer Chemotherapy and Pharmacology|January 1, 1988
When can the infusion period be safely ignored in the estimation of pharmacokinetic parameters of drugs in humans?L S Freedman, P WorkmanPageof 21